Free Trial

MGO Global (MGOL) Competitors

MGO Global logo
$0.31 -0.16 (-33.76%)
Closing price 02/19/2025 08:00 PM Eastern
Extended Trading
$0.31 0.00 (0.00%)
As of 02/19/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MGOL vs. SILO, EVKG, LULU, ONON, AS, BIRK, GIL, LEVI, BRP, and KTB

Should you be buying MGO Global stock or one of its competitors? The main competitors of MGO Global include Silo Pharma (SILO), Ever-Glory International Group (EVKG), Lululemon Athletica (LULU), ON (ONON), Amer Sports (AS), Birkenstock (BIRK), Gildan Activewear (GIL), Levi Strauss & Co. (LEVI), The Baldwin Insurance Group (BRP), and Kontoor Brands (KTB). These companies are all part of the "apparel" industry.

MGO Global vs.

MGO Global (NASDAQ:MGOL) and Silo Pharma (NASDAQ:SILO) are both small-cap retail/wholesale companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

MGO Global has a beta of 7.26, meaning that its share price is 626% more volatile than the S&P 500. Comparatively, Silo Pharma has a beta of -0.11, meaning that its share price is 111% less volatile than the S&P 500.

In the previous week, Silo Pharma had 1 more articles in the media than MGO Global. MarketBeat recorded 2 mentions for Silo Pharma and 1 mentions for MGO Global. MGO Global's average media sentiment score of 0.32 beat Silo Pharma's score of 0.00 indicating that MGO Global is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MGO Global
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Silo Pharma
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Silo Pharma has lower revenue, but higher earnings than MGO Global.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MGO Global$5.36M0.17-$7.14M-$4.57-0.07
Silo Pharma$70K86.40-$3.70MN/AN/A

MGO Global has a net margin of -142.93% compared to Silo Pharma's net margin of -5,255.05%. Silo Pharma's return on equity of -61.38% beat MGO Global's return on equity.

Company Net Margins Return on Equity Return on Assets
MGO Global-142.93% -412.85% -291.72%
Silo Pharma -5,255.05%-61.38%-47.49%

1.1% of MGO Global shares are held by institutional investors. Comparatively, 5.6% of Silo Pharma shares are held by institutional investors. 12.6% of MGO Global shares are held by insiders. Comparatively, 4.4% of Silo Pharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Silo Pharma received 1 more outperform votes than MGO Global when rated by MarketBeat users.

CompanyUnderperformOutperform
MGO GlobalN/AN/A
Silo PharmaOutperform Votes
1
100.00%
Underperform Votes
No Votes

Summary

Silo Pharma beats MGO Global on 7 of the 12 factors compared between the two stocks.

Get MGO Global News Delivered to You Automatically

Sign up to receive the latest news and ratings for MGOL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MGOL vs. The Competition

MetricMGO GlobalApparel IndustryRetail SectorNASDAQ Exchange
Market Cap$1.07M$5.21B$26.20B$9.09B
Dividend YieldN/A3.66%172.57%3.84%
P/E RatioN/A11.9421.6615.38
Price / Sales0.171.303.3284.08
Price / CashN/A12.9821.0537.22
Price / Book0.483.635.824.65
Net Income-$7.14M$183.11M$770.12M$245.69M
7 Day Performance-57.08%-3.19%-3.07%-2.67%
1 Month Performance-35.97%-4.16%-1.45%-2.16%
1 Year Performance-91.92%-13.10%7.19%12.90%

MGO Global Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MGOL
MGO Global
1.1338 of 5 stars
$0.31
-33.8%
N/A-92.2%$1.07M$5.36M0.007Gap Up
SILO
Silo Pharma
0.8392 of 5 stars
$1.42
-6.0%
N/A-12.9%$6.36M$70,000.000.002
EVKG
Ever-Glory International Group
N/A$0.00
flat
N/AN/A$0.00N/A0.004,300
LULU
Lululemon Athletica
4.3757 of 5 stars
$366.68
-6.2%
$399.14
+8.9%
-19.1%$44.65B$9.62B26.4838,000Positive News
High Trading Volume
ONON
ON
3.3887 of 5 stars
$51.94
-0.8%
$59.73
+15.0%
+52.8%$32.70B$2.16B120.792,353Positive News
AS
Amer Sports
3.4132 of 5 stars
$31.00
+0.4%
$28.64
-7.6%
+93.7%$16.93B$4.37B-221.3811,400Upcoming Earnings
BIRK
Birkenstock
3.2324 of 5 stars
$55.17
-3.1%
$68.31
+23.8%
-0.3%$10.36B$1.80B51.097,400Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
GIL
Gildan Activewear
4.7326 of 5 stars
$50.95
-0.2%
$54.78
+7.5%
+54.1%$7.77B$3.20B20.1443,000Earnings Report
Dividend Increase
Analyst Forecast
Analyst Revision
News Coverage
LEVI
Levi Strauss & Co.
3.8903 of 5 stars
$18.32
+0.5%
$21.27
+16.1%
+2.6%$7.25B$6.36B35.2218,700
BRP
The Baldwin Insurance Group
1.8637 of 5 stars
$41.69
+0.2%
$34.80
-16.5%
+52.1%$4.90B$1.27B-45.329,200Upcoming Earnings
News Coverage
KTB
Kontoor Brands
3.4789 of 5 stars
$83.60
+0.1%
$95.00
+13.6%
+40.8%$4.61B$2.61B18.8313,700Dividend Announcement
Analyst Forecast
Short Interest ↓
News Coverage

Related Companies and Tools


This page (NASDAQ:MGOL) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners